Frost & Sullivan Recognizes OSNovative for its Self-Adaptive Enluxtra Wound Care Technology

-- Functionalities such as higher absorption and moisture adaptability differentiate Enluxtra from competitors

MOUNTAIN VIEW, California, June 16, 2014 /PRNewswire/ -- Based on its recent analysis of the wound care dressing market, Frost & Sullivan recognizes OSNovative Systems Inc. with the 2014 North American Frost & Sullivan Award for New Product Innovation Leadership. The company's self-adaptive wound dressing, Enluxtra™, provides better clinical outcomes, remarkably simplifies wound care procedures and significantly reduces cost of care. Enluxtra uses OSNovative's innovative, feedback-driven technology to offer the best solution for standardizing wound care in home and field medicine.

Enluxtra represents a fundamentally new category of dynamic, multifunctional, self-adaptive wound care products. While in direct contact with the wound, the dressing material is capable of sensing and analyzing the wound condition. It then automatically and reversibly adjusts its function to accommodate the wound's needs, which may frequently and unpredictably change.

The dressing's ability to automatically adjust its function depending on the wound's needs allows clinicians to keep the dressing on the wound significantly longer, resulting in fewer disruptions of wound homeostasis, which is a known critical condition for fast wound healing.

The introduction of this proprietary, self-adaptive wound care technology opens a new direction in modern wound care delivery, bringing it to a more advanced level of clinical care, while dramatically reducing treatment costs for care providers and patients.

In view of the deepening financial constraints of society, self-adaptive wound care technology may help to meet the fast-growing demand for wound care, driven by an aging population and the spread of chronic diseases such as diabetes.

Enluxtra's adaptability to moisture levels makes the dressing an ideal choice for virtually any wound type. Higher absorption and structural integrity distinguish it from competing products. Further, Enluxtra overcomes the constraints associated with utilizing multiple products in the right order at the appropriate phase of healing, removing the guesswork from wound management.

Patients prefer Enluxtra for its drug-free pain reduction capabilities, excellent odor management, and reduced frequency of dressing changes. More than 20,000 patients have been treated with Enluxtra in the United States, an endorsement of the technology's superior qualities.

"The use of Enluxtra translates into significant cost-savings and successful treatment outcomes," said Frost & Sullivan Research Analyst Geethu Roshan Verghese. "By addressing the needs of healthcare professionals and patients alike, Enluxtra has effectively bridged vital gaps in the wound care industry."

Each year, Frost & Sullivan presents this award to the company that has developed an innovative element in a product by leveraging leading-edge technologies. The award recognizes the value-added features and increased ROI of the product, which, in turn, increases market penetration potential.

Frost & Sullivan's Best Practices Awards recognize companies in a variety of regional and global markets for outstanding achievement in areas such as leadership, technological innovation, customer service, and product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research.

About OSNovative Systems Inc.

OSNovative Systems, Inc. is a pioneer in self-adaptive wound care technology committed to developing, manufacturing and selling proprietary devices for advanced wound management, combat/emergency medicine and cosmetic skin care. This Silicon Valley-based start-up company is owned and managed by a team of dedicated professionals, who are passionate about bringing the most innovative wound care products to healthcare providers and patients.

For more information about self-adaptive technology, testimonies and clinical studies, please visit: www.AnyWound.com; or contact:
Polinak@osnovation.com
+1-650-483-9938

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies? Contact us: Start the discussion.

Mireya Espinoza
P: +1-210-247-3870
F: +1-210-348-1003
E: mireya.espinoza@frost.com